Activated small interfering RNA (siRNA) microneedles for pathological scar treatment

Summary:

A Singapore institute of higher learning has developed a world-first clinically effective and pain-free treatment of pathological scars using topical small interfering RNA (siRNA) microneedles. This patented technology comprises of a dissolvable microneedle containing activated siRNA for scar treatment. The team is currently working towards clinical trials.

Reference: TOSG20210201001

Country: Singapore

Submitted: 23. 4. 2021

View Partnering Opportunity

Keywords

Technology: Medical Technology / Biomedical Engineering; Pharmaceutical Products / Drugs.

Market: Other medical/health related (not elsewhere classified); Health and beauty aids.

NACE: -

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.